Recent Company News

• 08:00 PM ET Jul 11, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 12:29 PM ET Jul 18, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 20-Jul

• 08:53 AM ET Jul 11, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:00 PM ET Jul 14, 2025
  

  StreetAccount Summary - After-hours trading update

• 05:08 PM ET Jul 14, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:04 PM ET Jul 14, 2025
  

  Ascendis Pharma announces new data from Week 156 of Phase 3 PaTHway Trial for TransCon PTH (palopegteriparatide) in adults with hypoparathyroidism ($174.89, 0.00)

• 01:01 PM ET Jul 11, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 13-Jul